Given the potential for novel biomarkers to provide information beyond KDIGO staging, the 23rd Acute Disease Quality Initiative workgroup proposed an expanded classification for AKI adding biomarkers for each stage (Table 1).15 The first validation of this classification has been recently published using TIMP-2•IGFBP7 in adults with sepsis. Here, IGFBP7 is linked to acute kidney injury.